Calcium fructoborate is a naturally occurring boron compound – found in fruits, vegetables, and legumes – studied primarily for joint comfort and inflammation markers, with research suggesting it works even better when combined with resveratrol. The evidence base is real but modest in scale: a randomized controlled trial of 166 people and a smaller pilot study on knee osteoarthritis, not the large multi-thousand-person trials some other supplements have behind them.
Table of Contents
- What Is Calcium Fructoborate?
- The Angina Trial: What the Numbers Actually Show
- The Joint Comfort / Osteoarthritis Research
- How Calcium Fructoborate and Resveratrol Work Together
- Dosage and Safety
- Choosing a Product
What Is Calcium Fructoborate?
Calcium fructoborate (sometimes sold under the trade name FruiteX-B) is a “nature-identical” plant mineral complex – a naturally occurring form of soluble boron bound to fructose, found in fresh fruits, vegetables, nuts, and legumes, and manufactured commercially to match that natural structure. It’s water-soluble, non-GMO, and generally recognized as safe (GRAS). Research on calcium fructoborate has focused mainly on two areas: inflammation markers and cardiovascular function, and joint comfort in osteoarthritis.
Chemistry Note: Calcium fructoborate contains three forms of borate (diester, monoester, and boric acid), all biologically active. This structural difference from plain boric acid or borate is part of why researchers study it as a distinct compound rather than treating it as interchangeable with other boron sources.
The Angina Trial: What the Numbers Actually Show
The most substantial clinical evidence comes from a randomized, double-blind, active-controlled trial published in Nutrition (Scorei et al.), conducted in patients with stable angina pectoris. Researchers recruited 166 participants; 87 completed the full 60-day study across three groups: resveratrol alone (10 mg), calcium fructoborate alone (112 mg, providing 3 mg of boron daily), and a combination of both.
The results, measured at 30 and 60 days:
- CRP (C-reactive protein, an inflammation marker): decreased 39.7% in the calcium fructoborate-only group, 30.3% in the combination group, and 25% in the resveratrol-only group at 60 days.
- NT-proBNP (a marker of heart function): decreased most in the combination group (65.5%), compared to 59.7% for resveratrol alone and 52.6% for calcium fructoborate alone.
- Lipid markers: showed only slight changes from baseline across all groups.
- Quality of life: improved most in the group receiving the resveratrol and calcium fructoborate combination.
Context on trial size: This was a moderate-sized trial (87 completers across three groups, meaning roughly 25-30 people per group) in a specific patient population – people with diagnosed stable angina, not the general population. The results are genuine and published in a peer-reviewed journal, but they shouldn’t be read as proof of effect in healthy adults without cardiovascular disease, who weren’t studied here.
The Joint Comfort / Osteoarthritis Research
Separately, a pilot, double-blind, placebo-controlled study examined calcium fructoborate specifically for knee osteoarthritis, using WOMAC and McGill Pain Questionnaire scores – standard, validated tools for measuring joint pain and function. That research reported improved knee comfort and flexibility during a 2-week supplementation period, with fast-acting relief observed at a 108 mg twice-daily dose. As with the angina trial, this was a pilot study – an early, smaller-scale trial meant to establish a signal worth studying further, not a large confirmatory trial.
How Calcium Fructoborate and Resveratrol Work Together
The angina trial above is the clearest direct evidence for combining the two: the combination group showed the strongest reduction in NT-proBNP (a heart function marker) of the three groups tested, though calcium fructoborate alone produced the largest CRP reduction specifically. This suggests the two compounds may affect somewhat different aspects of inflammation and cardiovascular markers rather than simply duplicating each other’s effects – consistent with why they’re often formulated together rather than as a higher dose of either alone.
Dosage and Safety
The doses studied in the clinical research above are considerably lower than what “500 mg” style consumer products often contain – the angina trial used 112 mg of calcium fructoborate (3 mg boron), and the osteoarthritis pilot used 108 mg twice daily. This doesn’t necessarily mean higher-dose products are wrong, but it does mean the specific clinical results cited above were achieved at these more modest doses, not a larger amount. Calcium fructoborate has a long safety record in the research reviewed, with no significant adverse effects reported in these trials, though anyone pregnant, breastfeeding, or managing a health condition should consult a healthcare provider before starting any new supplement.
Choosing a Product
Since calcium fructoborate is often combined with resveratrol specifically because of research like the angina trial above, the same purity principles apply to both halves of a combination product: independent lab verification, no undisclosed fillers, and a clearly stated dose for each ingredient rather than a vague combined total.
Mega Resveratrol’s Resveratrol + Calcium Fructoborate combines both ingredients, manufactured without excipients and independently tested – the same standard covered in our guide on how to choose a resveratrol supplement.
Frequently Asked Questions
What is calcium fructoborate used for?
Research has studied it primarily for inflammation markers and cardiovascular function (in combination with resveratrol) and separately for joint comfort in osteoarthritis, using standard measures like CRP, NT-proBNP, and WOMAC pain scores.
Is calcium fructoborate the same as boron?
Related but not identical. Calcium fructoborate is a specific, naturally-occurring structural form combining boron with fructose, studied as a distinct compound from plain boric acid or other boron supplements.
How much calcium fructoborate was used in the clinical trials?
The angina trial used 112 mg daily (providing 3 mg of boron); the osteoarthritis pilot study used 108 mg twice daily. Both are lower than the total dose in some consumer combination products.
Does calcium fructoborate work better combined with resveratrol?
The available angina trial found the combination produced the strongest reduction in one marker (NT-proBNP) but not the strongest reduction in another (CRP, where calcium fructoborate alone performed best) – suggesting the two may act through somewhat different pathways rather than one simply amplifying the other.
Is the research on calcium fructoborate large-scale?
No. The angina trial had 87 completers across three groups, and the osteoarthritis research was a pilot study. Both are legitimate, peer-reviewed findings, but neither is a large, confirmatory trial.
Conclusion
Calcium fructoborate has real, peer-reviewed research behind it – a moderate-sized clinical trial in angina patients and a smaller pilot study on joint comfort – but the evidence base is early-stage rather than extensively confirmed at scale. The combination with resveratrol shows a specific, measurable effect on cardiovascular markers in the available trial, distinct from what either compound achieved alone. As with any supplement backed by promising but limited research, it’s worth treating the findings as a genuine signal worth watching, not a settled conclusion.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. These supplements are not intended to diagnose, treat, cure, or prevent any disease or medical condition. Always consult a qualified healthcare professional before starting any new supplement, especially if you are pregnant, breastfeeding, taking medications, or managing a health condition.
Resources cited:
- Scorei R, et al. “Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: effects on lipid profiles, inflammation markers, and quality of life.” Nutrition. 2012. https://pubmed.ncbi.nlm.nih.gov/23153742/
- “Short-term Intake of Calcium Fructoborate Improves WOMAC and McGill Scores and Beneficially Modulates Biomarkers Associated with Knee Osteoarthritis: A Pilot Clinical Double-blinded Placebo-controlled Study.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930945/
